Discovery of “unconventional” immune response opens new avenue in TB vaccine development

FHS
July 16, 2024
3:29 am

An “unconventional” immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.

NJHF awards $135K to Kessler Foundation scientists for pilot research projects

This year, New Jersey Health Foundation (NJHF) granted $135,000 in awards to three Kessler Foundation scientists to support pilot research projects that exhibit promising potential.

April 13, 2024

Eating in a ten-hour window has positive health benefits

Eating in a ten-hour window is associated with higher energy and mood and lower hunger levels, new results from the largest UK community science study

November 14, 2023

Amneal partners with mAbxience for denosumab biosimilars – Pharmaceutical Technology

Amneal has already launched three biosimilar products in the US. Credit: Shutterstock/JHVEPhoto. Amneal Pharmaceuticals and mAbxience have entered into an exclusive licensing agreement for the

October 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.